Abstract:When people around him yawn, he yawns. When the chatroom he is in starts discussing brownies, biscuits and chocolate-covered strawberries he finds himself salivating. He has perfect trust in authority. He is easily persuaded and always abides by authority's advice. These are all indications that he is very suggestible indeed. It is not difficult to distinguish between these individuals and those who are less suggestible. Those who are more easily impressionable include preschool children, women in weak health and persons with somatization disorders. We have noticed that many psychological, social and behavioural factors tend to influence the efficacy of medication and the overall therapeutic outcome for these individuals compared with those who are less suggestible. Over the last two decades little attention has been paid to two psychosocial dimensions of pharmacology. The first dimension includes the psychological response of patients and families to medications and pharmacotherapy. Individuals in modern countries may accept medications with unwavering belief in their effectiveness, whereas some ethnic groups do not. The second dimension that has been largely overlooked is the psychological, social and behavioural factors that influence drug metabolism, efficacy and side-effects. In order to describe the phenomenon as well as to differentiate it from psychopharmacology, we here coin a new term: psychosocialpharmacology[1]. Psychopharmacology studies drug-induced changes in mood, sensation, thinking and behaviour [2]. Psychosocialpharmacology is a new interdisciplinary approach that includes psychology, sociology and clinical pharmacology. It explores the puzzling efficacy differences associated with nonpharmacological factors among patients. It advocates considering the patient's psychological, social and behavioural components that influence drug efficacy in a similar manner as does the patient's genetics and physiology, and the disease itself. Furthermore, psychosocialpharmacology also studies the effect of the medical professional's manner and speech on medication efficacy. As a new element of pharmacology, we think that psychosocialpharmacology demands to answer the following questions: Since many major diseases from cancer to AIDS are involved with various affective disorders, in what manner and to what extent do mood disorders or personality types affect drug efficacy [3]? Are there differences in drug efficacy among individuals with dominant, compliant, introverted or extroverted personalities? It is well known that a good medical professional–patient relationship can be used to improve therapy, even in largely unknown, nonspecific and unpredictable ways. The generalized comfort and emotional support mechanisms are beneficial to patients [4, 5]. However, why does an empathic, physically attractive, likeable and competent medical professional contribute a positive pharmacotherapeutic outcome and, furthermore, how does it happen? What is the underlying hidden mechanism at work here? Most people in a developing country look favourably upon medicine from Western, developed countries. They have higher expectations of imported medicine and, whenever possible, they prefer it to homemade remedies. Is there any evidence to support the reasoning behind these beliefs? Informed consent refers to the permission given by a person prior to surgery or other types of medical treatment. The patient must understand the potential risks and benefits of the treatment and must legally agree to accept these inherent risks in writing. Obviously, the subtext of information provided by the medical professional inevitably contains suggestion. The question is: are we providing patients with information that is clinically helpful or harmful? More specifically, when providing information to individuals who are especially suggestible, does the medical professional use the power of positive suggestion to attain beneficial pharmacotherapeutic outcomes [6]? Many individuals around the world follow spiritual traditions. Spiritual complementary therapies are frequently used in both developed and developing countries. Do these social and cultural behaviours – religious rituals (such as prayer and exorcism), incantation, purgation, and cleansing of the mind by talking out the evil – augment the effects of medications? In summary, psychosocial factors have always played an important role in treating patients with medications, and we cannot overemphasize the importance of paying attention to these factors. It is because of this that we propose the term psychosocialpharmacology to arouse great care in the clinical pharmacology world. We expect that individuals of deep insight will take this issue into consideration.

Ethical considerations in clinical training, care and research in psychopharmacology

Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs

Ethical Issues in Neuroscience and Neuropsychiatric: A Review of Major Issues

Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications

Learning the "Science of the Art of Prescribing": From Evidence-based Algorithms to Individualized Medicine in Psychiatric Care

Developing an Ethics and Policy Framework for Psychedelic Clinical Care

Psychedelics and the treatment of eating disorders: considerations for future research and practice

Psychedelic research at a crossroads

Psychological, Social and Behavioural Factors That Influence Drug Efficacy: a Noteworthy Research Subject in Clinical Pharmacology

Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics

New Horizons in Pediatric Psychopharmacology

Ethical Considerations in Substance Use Treatment for Youth: Assessing Clinical Practices and Policy Frameworks for Potential Harm

Ethical issues in education and training.

Complexity of ethical decision making in psychiatry

Designing clinically useful psychopharmacological trials: challenges and ways forward

Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models

Toward Multidisciplinary Tools for Complex Clinical Psychopharmacology Cases: A Qualitative Study with French Healthcare Professionals

Educating the next generation of psychiatrists in the use of clinical neuromodulation therapies: what should all psychiatry residents know?

Beyond psychedelics: set and setting in general psychiatric practice

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

Professionalism and ethics education on relationships and boundaries: psychiatric residents' training preferences